Cases of Debilitating POTS Condition Rise After COVID-19; New Research Points to Possible Treatment

New research shows vagus nerve stimulation reduces POTS symptoms like rapid heartbeat, suggesting a potential breakthrough in managing the condition.

SciePro/Shutterstock

For the estimated 1 million to 3 million Americans living with postural orthostatic tachycardia syndrome (POTS), standing up can trigger a racing heartbeat, lightheadedness, and fainting that’s relieved only by sitting or lying down.

However, a new clinical trial offers a glimmer of hope for those desperate for relief. Researchers may have uncovered a novel, nonpharmaceutical way to manage this debilitating syndrome on the rise nationwide.

COVID-19 Pandemic and Vaccines Contribute to Uptick in POTS

POTS cases notably rose following the COVID-19 pandemic and vaccine rollout, both of which are known to impact heart health. Some evidence suggests that 2 percent to 14 percent of COVID-19 survivors are later diagnosed with POTS.